Glucagon-Like Peptide-1 Agonists: Cardiovascular Effects A Review
Veitla Rao, MD, Endocrinology Fellow
Objectives: Upon completion of this activity, participants will be able to: Describe a brief summary of GLP-Agonists. To identify Cardiovascular benefits of GLP-1 Agonists relevance in Type 2 diabetes mellitus.
For more information contact:
Department of Medicine/Endocrinology and Diabetes